Oncology research and targeted cancer therapies by Nuvectis Pharma

  • Hlib Chabaniuk
  • 14.05.2026
Nuvectis Pharma set to participate in key investor event at NASDAQ
Nuvectis Pharma announced its upcoming participation in the H.C. Wainwright 4th Annual BioConnect Investor Conference, taking place at NASDAQ. This event presents a strategic opportunity for ...
  • Eugene Komchuk
  • 05.05.2026
Nuvectis Pharma posts first quarter 2026 financial results and business update
Nuvectis Pharma has released its financial results for the first quarter of 2026 along with key business updates. The company shared its latest performance metrics and outlined recent strategic ...
  • Elena Nikulina
  • 31.03.2026
Nuvectis Pharma schedules NXP900 presentations for 2026 American Association for Cancer Research event
Nuvectis Pharma has announced its plans to present new findings on NXP900 at the 2026 American Association for Cancer Research (AACR) Meeting. This upcoming presentation will spotlight the ...
  • Ashutosh Sureka
  • 04.11.2025
Nuvectis Pharma reveals Q3 2025 financial performance and strategic business updates
Nuvectis Pharma, a key player in the pharmaceutical industry, has released its financial results for the third quarter of 2025. The company is providing detailed insights into its economic ...